首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Future medicinal chemistry

缩写:FUTURE MED CHEM

ISSN:1756-8919

e-ISSN:1756-8927

IF/分区:3.3/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引3091条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Sowmya Dastari,Nagula Shankaraiah Sowmya Dastari
In the recent past, spirooxindoles have been evolved as captivating structural architectures for the medicinal chemists, owing to their diverse biological activities. In particular, the development of spirocyclopropyl oxindole heterocycles ...
Amina Noor Ul Huda,Bibi Fatima Nayyab,Muhammad Hassham Hassan Bin Asad et al. Amina Noor Ul Huda et al.
Aim: 5'-Nucleotidase (5'-NT) enzyme has been reported for its detrimental effects post-Naja oxiana (N. oxiana) envenomation via generation of adenosine moiety. Therefore, the present study was designed to evaluate anti-5'...
Ami Thakkar,RajaSekhar Reddy Alavala,Ginpreet Kaur et al. Ami Thakkar et al.
Aim: The study combines computational and experimental approaches to provide structural and functional features of novel ligands, emphasizing their promising role as canditates for Alzheimer's disease (AD) drug developmen...
S Monica,P R Kavitha Rani,S Hari Prasad S Monica
Aims: Type 2 diabetes mellitus (T2DM) is an increasingly prevalent worldwide health problem, and new antidiabetic agents are needed to address the limitations of current therapies. The research aims to create and assess h...
Gautam Kumar,Rahul Kumar,Tanish et al. Gautam Kumar et al.
Aims: This study involves the semi-synthetic modification of (+)-usnic acid and the evaluation of the synthesized compounds for neuroprotective effects in scopolamine-injured C6 glial cells. ...
Memona Kamal,Nastaran Sadeghian,Feyzi Sinan Tokalı et al. Memona Kamal et al.
Aim: This study aimed to synthesize a new series of thiosemicarbazone derivatives (4a-r) as multifunctional antidiabetic candidates with dual α-glucosidase (α-Glu) inhibitory and antioxidant activities to address both h...
Safa Daoud,Mutasem Taha Safa Daoud
Glycogen synthase kinase-3β (GSK3β) has emerged as one of the most thoroughly validated therapeutic targets in modern drug discovery, with dysregulation implicated in neurodegenerative diseases, metabolic disorders, cancer, psychiatric co...
Menglin Luo,Shuwang Jiang,Yufeng Ma et al. Menglin Luo et al.
Tubulin represents a highly promising anticancer target and several inhibitors have been approved for cancer therapy. However, drug resistance and dose-dependent toxicity have limited clinical application. Recently, some novel pyrimidine de...
Sandipan Dash,Sheik Shehensha,Arghya Kusum Dhar et al. Sandipan Dash et al.
The inherent limitations of single-target cancer therapies, including drug resistance, toxicity, and inadequate efficacy against heterogeneous tumors, have catalyzed the strategic shift toward multi-targeted agents. The synergistic interpla...
Eslam B Elkaeed,Hazem Elkady,Walid E Elgammal et al. Eslam B Elkaeed et al.
Aims: This study aimed to design and synthesize a novel series of chromene derivatives as potential vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with anticancer activity. ...